|
⚲
|
| Keyboard |
| Mary Ann Gray | |
|---|---|
| Firm | |
| Address | c/o Rapt Therapeutics, Inc 561 Eccles Ave South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| RAPT Therapeutics Inc | 021-534152 | Director | 150.0 M of 150.0 M |
||
| Palisade Bio Inc | 021-505132 | Director | 2.5 M of 2.5 M |
||
| Palisade Bio Inc | 021-478383 | Director | 4.0 M of 4.0 M |
||
| Palisade Bio Inc | 021-471118 | Director | 2.5 M of 2.5 M |
||
| RAPT Therapeutics Inc | 021-448024 | Director | 50.0 M of 50.0 M |
||
| Palisade Bio Inc | 021-446416 | Director | 2.4 M of 2.4 M |
||
| Sarepta Therapeutics Inc | 021-361658 | Director | 400.0 M of 400.0 M |
||
| Seneca Biopharma Inc | 021-359133 | Director | 7.6 M of 7.6 M |
||
| Sarepta Therapeutics Inc | 021-354185 | Director | 30.5 M of 30.5 M |
||
| Acadia Pharmaceuticals Inc | 021-189257 | Director | 86.4 M of 86.4 M |
||
| Acadia Pharmaceuticals Inc | 021-154222 | Director | 21.1 M of 21.1 M |
||